CTA30X cell injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CTA30X cell injection, covering 2025-01-24 to 2025-01-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies [EARLY_Phase 1]